Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone

MeSH terms

• Antineoplastic Agents / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Antiretroviral Therapy, Highly Active
• Boronic Acids / therapeutic use*
• Bortezomib
• Cytarabine / administration & dosage
• Deoxycytidine / administration & dosage
• Deoxycytidine / analogs & derivatives
• Dexamethasone / administration & dosage
• Filgrastim
• Gemcitabine
• Granulocyte Colony-Stimulating Factor / administration & dosage
• HIV Infections / complications*
• HIV Infections / drug therapy
• Humans
• Lenalidomide
• Lymphoma, Large-Cell, Immunoblastic / drug therapy*
• Lymphoma, Large-Cell, Immunoblastic / pathology
• Lymphoma, Large-Cell, Immunoblastic / virology
• Male
• Neoplasm Staging
• Organoplatinum Compounds / administration & dosage
• Oxaliplatin
• Polyethylene Glycols
• Pyrazines / therapeutic use*
• Recombinant Proteins
• Thalidomide / analogs & derivatives
• Thalidomide / therapeutic use
• Young Adult